Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots
Spinal muscular atrophy (SMA) is a lower motor neuron disease, once considered incurable. The main symptoms are muscle weakness and muscular atrophy. More than 90% of cases of SMA are caused by homozygous deletion of survival motor neuron 1 (<i>SMN1</i>). Emerging treatments, such as spl...
Main Authors: | Yogik Onky Silvana Wijaya, Hisahide Nishio, Emma Tabe Eko Niba, Kentaro Okamoto, Haruo Shintaku, Yasuhiro Takeshima, Toshio Saito, Masakazu Shinohara, Hiroyuki Awano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/10/1621 |
Similar Items
-
High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed <i>SMN2</i> Splicing in Patient Fibroblasts
by: Yogik Onky Silvana Wijaya, et al.
Published: (2022-04-01) -
Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment
by: Hisahide Nishio, et al.
Published: (2023-07-01) -
Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Emma Tabe Eko Niba, et al.
Published: (2022-01-01) -
Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan
by: Tomokazu Kimizu, et al.
Published: (2021-07-01) -
Assessment of Spinal Muscular Atrophy Carrier Status by Determining <i>SMN1</i> Copy Number Using Dried Blood Spots
by: Yogik Onky Silvana Wijaya, et al.
Published: (2020-05-01)